Poly(ADP-ribose) polymerase-1 in acute neuronal death and inflammation: A strategy for neuroprotection

Annals of the New York Academy of Sciences

Volumn 993, Issue , 2003, Pages 217-228

  Skaper, Stephen D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cerebral ischemia; DNA repair; Neurodegeneration; Neuroinflammation; Neuroprotection; Neurotoxicity; Poly(ADP ribose) polymerase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE DIPHOSPHATE RIBOSE; CYTOKINE; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NUCLEAR PROTEIN; OXYGEN RADICAL; PROTEIN P53; UNCLASSIFIED DRUG;

BRAIN FUNCTION; BRAIN ISCHEMIA; CELL DAMAGE; CELL MIGRATION; CELL SURVIVAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE MODEL; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; ENZYME ACTIVATION; ENZYME MECHANISM; GENE ACTIVATION; GENE FUNCTION; GENETIC TRANSCRIPTION; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HYDROLYSIS; INFLAMMATION; MACROPHAGE MIGRATION; MICROGLIA; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPATHY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE METABOLISM; PARKINSONISM; SPINAL CORD INJURY;

EID: 0038727723     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07532.x     Document Type: Conference Paper

References (76)

1. DE MURCIA, G. & J. MENISSIER DE MURCIA. 1994. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem. Sci. 19: 172-176.
2. HERCEG, Z. & Z.Q. WANG. 2001. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity, and cell death. Mutat. Res. 477: 97-110.
3. MENISSIER-DE MURCIA, J., M. MOLINETE, G. GRADWOHL, et al. 1989. Zinc-binding domain of poly(ADPribose)polymerase participates in the recognition of single strand breaks on DNA. J. Mol. Biol. 210: 229-233.
4. POIRIER, G.G., G. DE MURCIA, J. JONGSTRA-BILEN, et al. 1982. Poly(ADPribosyl)ation of polynucleosomes causes relaxation of chromatin structure. Proc. Natl. Acad. Sci. USA 79: 3423-3427.
5. ALVAREZ-GONZALEZ, R., G. PACHECO-RODRIGUEZ & H. MENDOZA-ALVAREZ. 1994. Enzymology of ADP-ribose polymer synthesis. Mol. Cell Biochem. 138: 33-37.
6. SHALL, S. & G. DE MURCIA. 2001. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat. Res. 460: 1-15.
7. SATOH, M.S., G.G. POIRIER & T. LINDAHL. 1994. Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 33: 7099-7106.
8. FERRO, A.M. & B.M. OLIVERA. 1982. Poly(ADP-ribosylation) in vitro. Reaction parameters and enzyme mechanism. J. Biol. Chem. 257: 7808-7813.
9. SATOH, M.S. & T. LINDAHL. 1992. Role of poly(ADP-ribose) formation in DNA repair. Nature 356: 356-358.
10. PIEPER, A.A., A. VERMA, J. ZHANG & S.H. SNYDER. 1999. Poly (ADP-ribose) polymerase, nitric oxide, and cell death. Trends Pharmacol. Sci. 20: 171-181.
11. GAAL, J.C., K.R. SMITH & C.K. PEARSON. 1987. Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosylation in cellular metabolism. Trends Biochem. Sci. 12: 129-130.
12. LIPTON, S.A. & P.A. ROSENBERG. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330: 613-622.
13. CHOI, D.W. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634.
14. DAWSON, T.M. & V.L. DAWSON. 1997. Protection of the brain from ischemia. In Cerebrovascular Disease. H.H. Batjer, Ed.: 319-325. Lippincott-Raven, Philadelphia.
15. DAWSON, V.L., T.M. DAWSON, E.D. LONDON, et al. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88: 6368-6371.
16. DAWSON, V.L., V.M. KIZUSHI, P.L. HUANG, et al. 1996. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase deficient mice. J. Neurosci. 16: 2479-2487.
17. IADECOLA, C. 1997. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20: 132-139.
18. HUANG, Z., P.L. HUANG, N. PANAHIAN, et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885.
19. BECKMAN, J.S. & J.P. CROW. 1993. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21: 330-334.
20. SIESJO, B.K., C.D. AGARDH & F. BENGTSSON. 1989. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1: 165-211.
21. COSI, C., H. SUZUKI, D. MILANI, et al. 1994. Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J. Neurosci. Res. 39: 38-46.
22. ZHANG, J., V.L. DAWSON, T.M. DAWSON, et al. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689.
23. ELIASSON, M.J., K. SAMPEI, A.S. MANDIR, et al. 1997. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3: 1089-1095.
24. ENDRES, M., Z.Q. WANG, S. NAMURA, et al. 1997. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17: 1143-1151.
25. MANDIR, A.S., M.F. POITRAS, A.R. BERLINER, et al. 2000. NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J. Neurosci. 20: 8005-8011.
26. TOKIME, T., K. NOZAKI, T. SUGINO, et al. 1998. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 18: 991-997.
27. ENDRES, M., G. SCOTT, S. NAMURA, et al. 1998. Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci. Lett. 248: 41-44.
28. TAKAHASHI, K., J.H. GREENBERG, P. JACKSON, et al. 1997. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 17: 1137-1142.
29. TAKAHASHI, K., A.A. PIEPER, S.E. CROUL, et al. 1999. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 829: 46-54.
30. WILLIAMS, L., S. LIANG, S. LAUTAR, et al. 1999. GPI-6150, a potent PARP inhibitor, reduces infarct size following permanent and transient focal cerebral ischemia. Soc. Neurosci. (Abstr.) 25: 1061.
31. ABDELKARIM, G.E., K. GERTZ, C. HARMS, et al. 2001. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Intl. J. Mol. Med. 7: 255-260.
32. 2 cytotoxicity by inhibiting poly(ADP-ribose) polymerase. Biochem. Biophys. Res. Comm. 278: 590-598.
33. LOVE, S., R. BARBER & G.K. WILCOCK. 1998. Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man. NeuroReport 9: 955-959.
34. LOVE, S., R. BARBER & G.K. WILCOCK. 2000. Neuronal death in brain infarcts in man. Neuropathol. Appl. Neurobiol. 26: 55-66.
35. GOTO, S., R. XUE, N. SUGO, et al. 2002. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 33: 1101-1106.
36. MIWA, M. & T. SUGIMURA. 1971. Splitting of the ribose-ribose linkage of poly(adenosine diphosphate-ribose) by a calf thymus extract. J. Biol. Chem. 246: 6362-6364.
37. LU, X., Q. LIN, E. MASSUDA, et al. 2001. Post-ischemia treatment of a poly(ADP-ribose) glycohydrolase inhibitor provides neuro-protection against transient focal cerebral ischemia in rat. Soc. Neurosci. (Abstr.) 27: 2025.
38. MABUCHI, T., K. KITAGAWA, T. OHTSUKI, et al. 2000. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31: 1735-1743.
39. STOLL, G., S. JANDER & M. SCHROETER. 1998. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56: 149-171.
40. ULLRICH, O., A. DIESTEL, I. BECHMANN, et al. 2001. Turnover of oxidatively damaged nuclear proteins in BV-2 microglial cells is linked to their activation state by polyADP-ribose polymerase. FASEB J. 15: 1460-1462.
41. ULLRICH, O., A. DIESTEL & I.Y. EYÜPOGLU. 2001. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat. Cell. Biol. 3: 1035-1042.
42. KOEDEL, U., F. WINKLER, B. ANGELE, et al. 2002. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 22: 39-49.
43. HA, H.C., L.D. HESTER & S.H. SNYDER. 2002. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. USA 99: 3270-3275.
44. MCINTOSH, T.K. 1993. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J. Neurotrauma 10: 215-261.
45. WALLIS, R.A., K.L. PANIZZON & J.M. GIRARD. 1996. Traumatic neuroprotection with inhibitors of nitric oxide and ADP-ribosylation. Brain Res. 710: 169-177.
46. WHALEN, M.J., R.S.B. CLARK, C.E. DIXON, et al. 1999. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 19: 835-842.
47. COSI, C., F. COLPAERT, W. KOEK, et al. 1996. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res. 729: 264-269.
48. + and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res. 809: 58-67.
49. SCOTT, G.S., L.B. JAKEMAN, B.T. STOKES, et al. 1999. Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann. Neurol. 45: 120-124.
50. LAM, T.T. 1997. The effect of 3-aminobenzamide, an inhibitor of poly-ADP-ribose polymerase, on ischemia/reperfusion damage in rat retina. Res. Comm. Mol. Pathol. Pharmacol. 95: 241-252.
51. SCOTT, G.S., P. HAKE, R.B. KEAN, et al. 2001. Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 117: 78-86.
52. YAMAMOTO, H., Y. UCHIGATA & H. OKAMOTO. 1981. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294: 284-286.
53. PIEPER, A.A., T. WALLES, G. WEI, et al. 2000. Myocardial postischemic injury is reduced by polyADP-ribose polymerase-1 gene disruption. Mol. Med. 6: 271-282.
54. YANG, Z., B. ZINGARELLI & C. SZABO. 2000. Effect of genetic disruption of poly(ADP-ribose) synthetase delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13: 60-66.
55. BURKART, V., Z.Q. WANG, J. RADONS, et al. 1999. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat. Med. 5: 314-319.
56. PIEPER, A.A., D.J. BRAT, D.K. KRUG, et al. 1999. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96: 3059-3064.
57. FARO, R., Y. TOYODA, J.D. MCCULLY, et al. 2002. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor. Ann. Thorac. Surg. 73: 575-581.
58. SZABO, G., S. BAHRLE, N. STUMPF, et al. 2002. Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ. Res. 90: 100-106.
59. MABLEY, J.G., W.L. SUAREZ-PINZON, G. HASKO, et al. 2001. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzo-pyrone protects mice from multiple-low-dose streptozotocin-induced diabetes. Br. J. Pharmacol. 133: 909-919.
60. PACHER, P., L. LIAUDET, F.G. SORIANO, et al. 2002. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521.
61. SORIANO, F.G., L. LIAUDET, E. SZABO, et al. 2002. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 17: 286-292.
62. LIAUDET, L., F.G. SORIANO, E. SZABO, et al. 2000. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc. Natl. Acad. Sci. USA 97: 10203-10208.
63. OLIVER, F.J., J. MENOSSIER-DE MURCIA, C. NACCI, et al. 1999. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18: 4446-4454.
64. DRAZEN, D.L., D. BILU, N. EDWARDS, et al. 2000. Disruption of poly(ADP-ribose) polymerase (PARP) protects against stress-evoked immunocompromise. Mol. Med. 7: 761-766.
65. GOLDFARB, R.D., A. MARTON, E. SZABO, et al. 2002. Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit. Care Med. 30: 974-980.
66. MABLEY, J.G., P. JAGTAP, M. PERRETTI, et al. 2001. Anti-inflammatory effects of a novel, potent inhibitor of poly(ADP-ribose) polymerase. Inflamm. Res. 50: 561-569.
67. LIAUDET, L., A. SZABO, F.G. SORIANO, et al. 2000. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 14: 134-141.
68. THIEMERMANN, C., J. BOWES, F.P. MYINT, et al. 1997. Inhibition of the activity of poly(ADP-ribose) synthetase reduced ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 94: 679-683.
69. SZABO, C., L. VIRAG, S. CUZZOCREA, et al. 1998. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose synthase. Proc. Natl. Acad. Sci. USA 95: 3867-3872.
70. CUZZOCREA, S., B. ZINGARELLI, G. COSTANTINO, et al. 1997. Beneficial effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121: 1065-1074.
71. LA PAGE, C., J. SANCEAU, J.-C. DRAPIER, et al. 1998. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF-κB activation. Biochem. Biophys. Res. Comm. 243: 451-457.
72. HASSA, P.O. & M.O. HOTTIGER. 1999. A role of poly(ADP-ribose) polymerase in NF-kappaB transcriptional activation. J. Biol. Chem. 380: 953-959.
73. VAZIRI, H., M.D. WEST, R.C. ALLSOPP, et al. 1997. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose)polymerase. EMBO J. 16: 6018-6033.
74. CHIARUGI, A. 2002. Poly(ADP-ribose) polymerase: killer or conspirator? The "suicide hypothesis" revisited. Trends Pharmacol. Sci. 23: 122-129.
75. WANG, Z.Q., B. AUER, L. STINGL, et al. 1995. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9: 509-520.
76. PIEPER, A.A., S. BLACKSHAW, E.E. CLEMENTS, et al. 2000. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc. Natl. Acad. Sci. USA 97: 1845-1850.